Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2008

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2008. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​oc/​advisory/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2008. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).

Committee NameTentative Date of Meeting(s)Advisory Committee 10-Digit Information Line Code
OFFICE OF THE COMMISSIONER
Pediatric Advisory CommitteeMarch and November days to be announced8732310001
Risk Communication Advisory CommitteeFebruary 28-29, May 15-16, August 21-22, November 17-188732112560
Science Board to FDAMay and October days to be announced3014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeApril 29, October 173014512388
Blood Products Advisory CommitteeMay 1-2, August 14-15, December 11-123014519516
Cellular, Tissue and Gene Therapies Advisory CommitteeApril 10-11, November 13-143014512389
Start Printed Page 2508
Transmissible Spongiform Encephalopathies Advisory CommitteeTo be announced3014512392
Vaccines and Related Biological Products Advisory CommitteeFebruary 20-21, May 21-22, September 24-25, November 19-203014512391
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory CommitteeMarch 11, May days to be announced3014512529
Anti-Infective Drugs Advisory CommitteeFebruary 27-28, April 1-33014512530
Antiviral Drugs Advisory CommitteeTo be announced3014512531
Arthritis Advisory CommitteeJuly, September, and November days to be announced3014512532
Cardiovascular and Renal Drugs Advisory CommitteeJune 24-25, August 19-20, December 9-103014512533
Dermatologic and Ophthalmic Drugs Advisory CommitteeApril days to be announced3014512534
Drug Safety and Risk Management Advisory CommitteeFebruary 1, May days to be announced3014512535
Endocrinologic and Metabolic Drugs Advisory CommitteeApril 16-17, July 1-2, October 29-30, November 19-203014512536
Gastrointestinal Drugs Advisory CommitteeJanuary 23, May days to be announced3014512538
Nonprescription Drugs Advisory CommitteeTo be announced3014512541
Oncologic Drugs Advisory CommitteeMarch 13, April days to be announced, May 30, September 10-11, December 15-163014512542
Peripheral and Central Nervous System Drugs Advisory CommitteeMay days to be announced3014512543
Pharmaceutical Science and Clinical Pharmacology, Advisory Committee forMarch 18-193014512539
Psychopharmacologic Drugs Advisory CommitteeFebruary 63014512544
Pulmonary-Allergy Drugs Advisory CommitteeFebruary 203014512545
Reproductive Health Drugs, Advisory Committee forTo be announced3014512537
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeAugust 12, October 20-213014512398
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices PanelJanuary 23, March 26, September 173014512624
Circulatory System Devices PanelAugust 26-27, November 14-153014512625
Clinical Chemistry and Clinical Toxicology Devices PanelApril 9-10, August 13-14, December 4-53014512514
Dental Products PanelJune 11, September 10, November 193014512518
Ear, Nose, and Throat Devices PanelApril 16-17, June 25-26, August 28-29, October 28-29, December 10-113014512522
Gastroenterology-Urology Devices PanelOctober 173014512523
General and Plastic Surgery Devices PanelJune 10-11, October 21-223014512519
General Hospital and Personal Use Devices PanelMay 6-7, September 16-173014512520
Hematology and Pathology Devices PanelApril 25, October 173014512515
Immunology Devices PanelNovember 6-73014512516
Medical Devices Dispute Resolution PanelTo be announced as needed3014510232
Microbiology Devices PanelApril 24-25, June 19-20, October 23-243014512517
Start Printed Page 2509
Molecular and Clinical Genetics PanelMay 6-7, November 11-123014510231
Neurological Devices PanelMarch 25-26, June 3-4, September 23-24, November 6-73014512513
Obstetrics and Gynecology Devices PanelApril 17-18, June 19-20, August 14-15, October 16-17, December 11-123014512524
Ophthalmic Devices PanelFebruary 21-22, May 15-16, September 18-19, November 20-213014512396
Orthopedic and Rehabilitation Devices PanelApril 21-22, June 16-17, August 18-19, October 20-21, December 8-93014512521
Radiological Devices PanelApril 15-16, August 12, November 43014512526
National Mammography Quality Assurance Advisory CommitteeOctober 13-143014512397
Technical Electronic Product Radiation Safety Standards CommitteeOctober 83014512399
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeJuly 22, December 23014510564
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeMarch day to be announced3014512548
National Center for Toxicological Research (NCTR)
Science Advisory Board to NCTRAugust 12-133014512559
Start Signature

Dated: January 7, 2008.

Randall W. Lutter,

Deputy Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. E8-567 Filed 1-14-08; 8:45 am]

BILLING CODE 4160-01-S